Cara Therapeutics | CARA - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Acadia Pharmaceuticals USD 976.45M 19.97M 2026-09
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Cara Therapeutics USD 22.28M 2.42M 2026-09
Cassava Sciences USD 46.99M 35.69M 2026-09
Chugai Pharma JPY 382.3B 8.13B 2026-09
Cipla INR 16.59B 6.41B 2026-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 10.28M 2.15M 2026-06
CSL USD 2.16B 633M 2025-06
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 1.03B 866.85M 2026-09
J&J USD 16.91B 3.51B 2026-09
Neurocrine Biosciences USD 641.5M 309.1M 2026-09
Pacira USD 1.79B 1.58B 2026-09
Pfizer USD 1.82B 848M 2026-09
RedHill Biopharma USD 2.87M 1.75M 2025-06
Supernus Pharmaceuticals USD 175.88M 4.07M 2026-09
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12